Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its ...

Weight loss injections are popular among adults, but a new study suggest they could be useful in fighting childhood obesity, ...

Joplin, who misfired on the potential winning score earlier in overtime, received a long outlet pass from Redwood goalkeeper ...

Shares in Roche fell on Thursday after an early-stage obesity pill candidate that carries high market hopes was linked to a ...

Roche has already budgeted for future commercial manufacturing builds and established a network of contract manufacturers as ...

Swiss drug major Roche (RHHBY) announced Monday that the United States Food and Drug Administration has approved OCREVUS ZUNOVO ...

Stifel Nicolaus analyst Eric Le Berrigaud has maintained their neutral stance on RHHVF stock, giving a Hold rating today. Eric Le ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage ...

The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...

The FDA has approved Roche’s subcutaneous injection for relapsing multiple sclerosis (RMS) and primary progressive multiple ...